| abstract |
(57) [Summary]nCholesteryl ester transfer protein inhibitors of formula (I), prodrugs thereof, or pharmaceutically acceptable salts of the compounds or prodrugs thereof, pharmaceutical compositions comprising such inhibitors and high density lipoprotein-cholesterol Low HDL cholesterol and / or high levels in certain plasma lipid concentrations, including, for example, LDL-cholesterol and triglyceride reduction, and therefore in certain mammals, including humans, Use of such inhibitors in the treatment of diseases exacerbated by concentrations of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases. |